Labiotech.eu

News and Trends 20 Apr 2023

FDA approves Genentech’s lymphoma drug

Genentech, a member of the Roche Group, has announced the U.S. Food and Drug Administration (FDA) has approved Polivy (polatuzumab vedotin-piiq) in combination with Rituxan (rituximab), cyclophosphamide, doxorubicin and prednisone (R-CHP). The approval covers the treatment of adult patients who have previously untreated diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS) or high-grade B-cell […]

April 20, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 20 Apr 2023

Hasten raises $315M for acquisitions and pipeline development

CBC Group, Asia’s largest healthcare-dedicated investment firm headquartered in Singapore, and Hasten Biopharmaceutic Company Limited, have completed a $315 million fundraising round for Hasten. Hasten is a Chinese biopharma company backed by CBC, Hefei Industry Investment Group, and Feidong County of Hefei City. The fundraising round was co-led by CBC and Abu Dhabi sovereign wealth […]

April 20, 2023 - 2 minutesmins - By Jim Cornall

8 life science innovators you must meet at BioTrinity 2023

April 20, 2023 - 4 minutesmins - By External Contributor

PhD students Elisa Zattarin and Olof Eskilsson.

News and Trends 19 Apr 2023

Wound treatment boost from new color-changing dressing

A nanocellulose wound dressing that can reveal early signs of infection without interfering with the healing process has been developed by researchers at Linköping University, Sweden. The study, published in Materials Today Bio, is another step on the road to a new type of wound care. The skin is the largest organ of the human […]

April 19, 2023 - 5 minutesmins - By Jim Cornall

In Depth 19 Apr 2023

How Vaccine Platforms Can Prepare Us for Future Pandemics

The COVID-19 pandemic exposed the weaknesses in our defenses. Vaccine platforms will be powerful tools for reacting faster to future pandemics. Multiple COVID-19 vaccines became available across the world to tackle the COVID-19 pandemic, signaling a historic moment for vaccine development due to the speed at which they were created. And with scientists believing that […]

April 19, 2023 - 7 minutesmins - By Sachin Rawat

News and Trends 19 Apr 2023

Forbion raises €1.35B to invest in life science companies

European life sciences venture capital firm Forbion has raised €1.35 billion ($1.5 billion) for its two newest funds, bringing the total of funds under management to €3 billion ($3.3 billion). Both funds exceeded the original target sizes and represent Forbion’s largest fundraising to date. The final close of the Forbion Ventures Fund VI has reached […]

April 19, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 19 Apr 2023

Nanocages developed to deliver small interfering RNAs

Small interfering RNAs (siRNAs) are novel therapeutics that can be used to treat a wide range of diseases. This has led to a growing demand for selective, efficient, and safe ways of delivering siRNA in cells. Now, in a cooperation between the universities of Amsterdam and Leiden in the Netherlands, researchers have developed dedicated molecular […]

April 19, 2023 - 4 minutesmins - By Jim Cornall

Expert Advice 18 Apr 2023

Pharmacovigilance – how to deal with the data

By Axel Hagel, practice leader, PV & RM services, IQVIA Life science data, especially safety data, is exploding. It is estimated that pharmaceutical data is increasing at a rate of 36% annually. This is more than other data-driven industries including finance (26% YoY) and manufacturing (30% YoY). This increase is in part due to digital […]

April 18, 2023 - 6 minutesmins - By External Contributor

In Depth 18 Apr 2023

Gene therapy: a powerful tool for hemophilia B?

The approval of HEMGENIX, the first-ever gene therapy for hemophilia B, by the U.S. Food and Drug Administration (FDA) followed by the European Commission, has been momentous in rare disease therapeutic research, paving the way for various gene therapies that are currently being studied. As we observed World Hemophilia Day on April 17, let us […]

April 18, 2023 - 10 minutesmins - By Roohi Mariam Peter

News and Trends 18 Apr 2023

Complement Therapeutics raises €72M for eye condition gene therapy

Complement Therapeutics GmbH (CTx), a preclinical stage biotechnology company developing novel therapeutics for complement mediated diseases, has completed a €72 million ($78.7 million) Series A financing. The round was led by Gimv, a Belgian-based private equity and venture capital fund, co-led by Forbion as existing investor and further joined by BioGeneration Ventures (BGV), Panakes Partners, […]

April 18, 2023 - 3 minutesmins - By Jim Cornall

C diff Clostridium difficile Clostridioides

News and Trends 17 Apr 2023

Swedish bacterial resistance study could pave road to new antibiotics

A species of ordinary gut bacteria flourishes when the intestinal flora is knocked out by a course of antibiotics. Since the bacteria are naturally resistant to many antibiotics, this can cause problems. A study at Lund University in Sweden now shows how two molecular mechanisms can work together to make the bacterium extra resistant. “Using […]

April 17, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 17 Apr 2023

Aer Therapeutics raises $36M to tackle lung diseases

Aer Therapeutics, a joint University College Dublin (UCD) and University of California, San Francisco (UCSF) biopharmaceutical spin-out company developing novel inhaled treatments for muco-obstructive lung diseases, has announced the closing of a $36 million Series A financing round.Funding was received from a syndicate of premier life science industry investors, including Canaan, OrbiMed, and Hatteras Venture […]

April 17, 2023 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

FDA approves Genentech’s lymphoma drug

Hasten raises $315M for acquisitions and pipeline development

8 life science innovators you must meet at BioTrinity 2023

Wound treatment boost from new color-changing dressing

How Vaccine Platforms Can Prepare Us for Future Pandemics

Forbion raises €1.35B to invest in life science companies

Nanocages developed to deliver small interfering RNAs

Pharmacovigilance – how to deal with the data

Gene therapy: a powerful tool for hemophilia B?

Complement Therapeutics raises €72M for eye condition gene therapy

Swedish bacterial resistance study could pave road to new antibiotics

Aer Therapeutics raises $36M to tackle lung diseases

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!